These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 39337010)

  • 21. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
    Gardenghi S; Ramos P; Marongiu MF; Melchiori L; Breda L; Guy E; Muirhead K; Rao N; Roy CN; Andrews NC; Nemeth E; Follenzi A; An X; Mohandas N; Ginzburg Y; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
    J Clin Invest; 2010 Dec; 120(12):4466-77. PubMed ID: 21099112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis.
    Nemeth E; Ganz T
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Advances in Regulating the Hepcidin/Ferroportin Axis.
    Hawula ZJ; Wallace DF; Subramaniam VN; Rishi G
    Pharmaceuticals (Basel); 2019 Nov; 12(4):. PubMed ID: 31775259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological Targeting of the Hepcidin/Ferroportin Axis.
    Sebastiani G; Wilkinson N; Pantopoulos K
    Front Pharmacol; 2016; 7():160. PubMed ID: 27445804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.
    Nemeth E
    Adv Hematol; 2010; 2010():750643. PubMed ID: 20066043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.
    Nekhai S; Xu M; Foster A; Kasvosve I; Diaz S; Machado RF; Castro OL; Kato GJ; Taylor JG; Gordeuk VR
    Haematologica; 2013 Mar; 98(3):455-63. PubMed ID: 23065513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-Thalassemia: evolving treatment options beyond transfusion and iron chelation.
    Langer AL; Esrick EB
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):600-606. PubMed ID: 34889443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease.
    Karaskova E; Pospisilova D; Velganova-Veghova M; Geryk M; Volejnikova J; Holub D; Hajduch M
    Dig Dis Sci; 2021 Oct; 66(10):3263-3269. PubMed ID: 33063192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of iron metabolic enzyme hepcidin expression levels with the prognosis of patients with pancreatic cancer.
    Toshiyama R; Konno M; Eguchi H; Asai A; Noda T; Koseki J; Asukai K; Ohashi T; Matsushita K; Iwagami Y; Yamada D; Asaoka T; Wada H; Kawamoto K; Gotoh K; Kudo T; Satoh T; Doki Y; Mori M; Ishii H
    Oncol Lett; 2018 May; 15(5):8125-8133. PubMed ID: 29731920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.
    Billesbølle CB; Azumaya CM; Kretsch RC; Powers AS; Gonen S; Schneider S; Arvedson T; Dror RO; Cheng Y; Manglik A
    Nature; 2020 Oct; 586(7831):807-811. PubMed ID: 32814342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferroportin-inhibitor salt: patent evaluation WO2018192973.
    Kadam S; Khaitan M; Banerjee P; Mandhare A
    Expert Opin Ther Pat; 2021 Jul; 31(7):585-595. PubMed ID: 33975503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling Systemic Iron Regulation during Dietary Iron Overload and Acute Inflammation: Role of Hepcidin-Independent Mechanisms.
    Enculescu M; Metzendorf C; Sparla R; Hahnel M; Bode J; Muckenthaler MU; Legewie S
    PLoS Comput Biol; 2017 Jan; 13(1):e1005322. PubMed ID: 28068331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Therapeutic Advances in β-Thalassemia.
    Makis A; Voskaridou E; Papassotiriou I; Hatzimichael E
    Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34207028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
    Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
    Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased iron export by ferroportin induces restriction of HIV-1 infection in sickle cell disease.
    Kumari N; Ammosova T; Diaz S; Lin X; Niu X; Ivanov A; Jerebtsova M; Dhawan S; Oneal P; Nekhai S
    Blood Adv; 2016 Dec; 1(3):170-183. PubMed ID: 28203649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutual Cross Talk Between Iron Homeostasis and Erythropoiesis.
    Rybinska I; Cairo G
    Vitam Horm; 2017; 105():143-160. PubMed ID: 28629515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disordered hepcidin-ferroportin signaling promotes breast cancer growth.
    Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S
    Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload.
    Mohammad G; Matakidou A; Robbins PA; Lakhal-Littleton S
    Kidney Int; 2021 Sep; 100(3):559-569. PubMed ID: 33991530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of blood transfusion on serum hepcidin levels in chronically transfused patients of β-thalassemia major: An observational study in a tertiary care centre in Western Maharashtra.
    Bhowmik S; Biswas AK; Baranwal AK; Pawar AA; Dimri U
    Asian J Transfus Sci; 2024; 18(1):73-78. PubMed ID: 39036689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.